CytomX Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $-44.3M | $8.7M |
| FY2014 | $1.6M | $-78.5M | $64.4M |
| FY2015 | — | $126.1M | $59.8M |
| FY2016 | — | $78.5M | $104.6M |
| FY2017 | — | $69.9M | $177.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $-44.3M | $8.7M |
| FY2014 | $1.6M | $-78.5M | $64.4M |
| FY2015 | — | $126.1M | $59.8M |
| FY2016 | — | $78.5M | $104.6M |
| FY2017 | — | $69.9M | $177.5M |